3Tinmouth AT, McIntyre LA, Fowler RA. Blood conservation strategies to reduce the need for red blood cell transfusion in critically ill patients[J]. CMAJ, 2008,178:49 -57.
4Michiels JJ, van Vliet HH, Berneman Z, et al. Intravenous DDAVP and factor VIII-yon Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With yon Willebrand disease type 1,2 and 3[J]. Clin Appl Thromb Hemost, 2007,13:14 -34.
5Upanhyay A, Jaber BL, Madiaas NE. Incidence and prevalence of hyponatremia[J]. Am J Meb ,2006,119 ( suppl 1 ) : S30 - S35.
6Schrier RW. Treatment of hyponatremia[ J]. N Engl J Med, 1985, 312:1121 - 1123.
7Stems RH. Cappuccio JD, Silver SM, et al. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective [ J ]. J Am Soc Nephrol, 1994,4 : 1522 - 1530.
8Verbalis JG. Hyponatremia: endocrinologic causes and consequences of therapy [J]. Trends Endocrinol Metad, 1992,3 : 1 - 7.
9Lin SH, Chau T, Wu CC, et al. Osmotic demyelination syndrome after correction of chronic hyponatremia with norm Saline [ J ]. Am J Med Sci ,2002,323:259 - 2304.
10Sonnenblick M, Friedlander Y, Rosin AJ. Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients [ J ]. Chest,1993,103:601 -606.
